186 related articles for article (PubMed ID: 34196768)
1. Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Volk T; Warnatz K; Marks R; Urbach H; Schluh G; Strohmeier V; Rojas-Restrepo J; Grimbacher B; Rauer S
J Neurol; 2022 Feb; 269(2):973-981. PubMed ID: 34196768
[TBL] [Abstract][Full Text] [Related]
2. Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab.
Varmpompiti K; Westwood AJ; Ben-Joseph A; Sibtain N; Ibrahim MAA; Stanton B; Zuckerman M; Hadden R; Ritter LM
J Neuroimmunol; 2023 Dec; 385():578248. PubMed ID: 37995595
[TBL] [Abstract][Full Text] [Related]
3. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
[TBL] [Abstract][Full Text] [Related]
4. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review.
Lan TY; Chen YS; Cheng CF; Huang ST; Shen CY; Hsu PN
Lupus; 2021 Oct; 30(11):1849-1855. PubMed ID: 34325541
[TBL] [Abstract][Full Text] [Related]
5. Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab.
Boesl F; Allers K; Herm J; Scheider T; Franke C
J Neurovirol; 2022 Apr; 28(2):335-338. PubMed ID: 35320511
[TBL] [Abstract][Full Text] [Related]
6. Pembrolizumab treatment of inflammatory progressive multifocal leukoencephalopathy: a report of two cases.
Darcy S; Alexander M; McCarthy A; O'Dowd S
J Neurovirol; 2022 Feb; 28(1):145-150. PubMed ID: 34874539
[TBL] [Abstract][Full Text] [Related]
7. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
Holmes A; Wellings T; Walsh O; Rowlings P
J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
[TBL] [Abstract][Full Text] [Related]
8. Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors.
Boumaza X; Bonneau B; Roos-Weil D; Pinnetti C; Rauer S; Nitsch L; Del Bello A; Jelcic I; Sühs KW; Gasnault J; Goreci Y; Grauer O; Gnanapavan S; Wicklein R; Lambert N; Perpoint T; Beudel M; Clifford D; Sommet A; Cortese I; Martin-Blondel G;
Ann Neurol; 2023 Feb; 93(2):257-270. PubMed ID: 36151879
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?
Roos-Weil D; Weiss N; Guihot A; Uzunov M; Bellanger A; Eymard B; Saadoun D; Houillier C; Idbaih A; Demeret S; Deback C; Leblond V; Galanaud D; Shor N; Pourcher V
J Neurol; 2021 Jul; 268(7):2458-2465. PubMed ID: 33515299
[TBL] [Abstract][Full Text] [Related]
10. Pembrolizumab for the treatment of Progressive Multifocal Leukoencephalopathy (PML) in a patient with AIDS: A case report and literature review.
Chatterjee T; Roy M; Lin RC; Almoujahed MO; Ahmad S
IDCases; 2022; 28():e01514. PubMed ID: 35637642
[TBL] [Abstract][Full Text] [Related]
11. Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy in China.
Fan S; Liu M; Bai L; Chen S; Hou B; Lin N; Yuan J; Mao C; Niu J; Ren H; Zhao Y; Zhang Z; Zhu Y; Peng B; Guan H
J Neurovirol; 2023 Dec; 29(6):692-698. PubMed ID: 37898569
[TBL] [Abstract][Full Text] [Related]
12. Progressive multifocal leukoencephalopathy treated with nivolumab.
Hoang E; Bartlett NL; Goyal MS; Schmidt RE; Clifford DB
J Neurovirol; 2019 Apr; 25(2):284-287. PubMed ID: 30864100
[TBL] [Abstract][Full Text] [Related]
13. Novel treatments for progressive multifocal leukoencephalopathy.
Bennett KM; Fernandes PM
Br J Hosp Med (Lond); 2020 Jul; 81(7):1-9. PubMed ID: 32730143
[TBL] [Abstract][Full Text] [Related]
14. A Chronic Lymphocytic Leukemia Patient with Progressive Multifocal Leukoencephalopathy Caused by John Cunningham Virus.
Ramadhani P; Bramantono B; Sedana MP
Acta Med Indones; 2018 Apr; 50(2):151-158. PubMed ID: 29950535
[TBL] [Abstract][Full Text] [Related]
15. Progressive multifocal leukoencephalopathy, advanced ductal breast carcinoma, systemic sclerosis, and checkpoint inhibitors: a therapeutic dilemma.
Baena-Álvarez B; Rodríguez-Jorge F; Beltrán-Corbellini Á; Cortés-Salgado A; De la Puente C; Corral Í
J Neurovirol; 2023 Feb; 29(1):116-119. PubMed ID: 36348234
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Intravenous Methylprednisolone on Recurrent Exacerbation in Hematologic Malignancy-associated Progressive Multifocal Leukoencephalopathy.
Nakamura R; Kitamura A; Tsukamoto T; Tamura R; Ogawa N; Yamakawa I; Kim H; Kawai M; Sanada M; Urushitani M
Intern Med; 2021 Apr; 60(8):1287-1291. PubMed ID: 33229808
[TBL] [Abstract][Full Text] [Related]
17. Update on progressive multifocal leukoencephalopathy.
Steiner I; Berger JR
Curr Neurol Neurosci Rep; 2012 Dec; 12(6):680-6. PubMed ID: 22991070
[TBL] [Abstract][Full Text] [Related]
18. Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV.
Corey S; Smith BR; Cortese ICM
Curr HIV/AIDS Rep; 2022 Dec; 19(6):580-591. PubMed ID: 36181625
[TBL] [Abstract][Full Text] [Related]
19. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).
Bauer J; Gold R; Adams O; Lassmann H
Acta Neuropathol; 2015 Dec; 130(6):751-64. PubMed ID: 26323992
[TBL] [Abstract][Full Text] [Related]
20. The human JC polyomavirus (JCPyV): virological background and clinical implications.
Hirsch HH; Kardas P; Kranz D; Leboeuf C
APMIS; 2013 Aug; 121(8):685-727. PubMed ID: 23781977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]